Class information for:
Level 1: FULMINANT TYPE 1 DIABETES//HEPATIC GLYCOGENOSIS//MAURIAC SYNDROME

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
28368 170 26.2 76%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
702 12214 TYPE 1 DIABETES//DIABETIC KETOACIDOSIS//BARBARA DAVIS CHILDHOOD DIABET

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FULMINANT TYPE 1 DIABETES Author keyword 71 84% 22% 38
2 HEPATIC GLYCOGENOSIS Author keyword 9 83% 3% 5
3 MAURIAC SYNDROME Author keyword 9 83% 3% 5
4 GLYCOGENIC HEPATOPATHY Author keyword 8 100% 3% 5
5 FULMINANT TYPE 1 DIABETES MELLITUS Author keyword 4 50% 4% 6
6 TYPE 1B DIABETES Author keyword 3 50% 2% 4
7 STEM CELL EDUCATOR THERAPY Author keyword 2 67% 1% 2
8 METAB DIABET CLIN NUTR Address 2 20% 6% 10
9 FULMINANT Author keyword 2 15% 6% 10
10 GEN INTERNAL MED METAB Address 1 40% 1% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 FULMINANT TYPE 1 DIABETES 71 84% 22% 38 Search FULMINANT+TYPE+1+DIABETES Search FULMINANT+TYPE+1+DIABETES
2 HEPATIC GLYCOGENOSIS 9 83% 3% 5 Search HEPATIC+GLYCOGENOSIS Search HEPATIC+GLYCOGENOSIS
3 MAURIAC SYNDROME 9 83% 3% 5 Search MAURIAC+SYNDROME Search MAURIAC+SYNDROME
4 GLYCOGENIC HEPATOPATHY 8 100% 3% 5 Search GLYCOGENIC+HEPATOPATHY Search GLYCOGENIC+HEPATOPATHY
5 FULMINANT TYPE 1 DIABETES MELLITUS 4 50% 4% 6 Search FULMINANT+TYPE+1+DIABETES+MELLITUS Search FULMINANT+TYPE+1+DIABETES+MELLITUS
6 TYPE 1B DIABETES 3 50% 2% 4 Search TYPE+1B+DIABETES Search TYPE+1B+DIABETES
7 STEM CELL EDUCATOR THERAPY 2 67% 1% 2 Search STEM+CELL+EDUCATOR+THERAPY Search STEM+CELL+EDUCATOR+THERAPY
8 FULMINANT 2 15% 6% 10 Search FULMINANT Search FULMINANT
9 CYTOTOXIC T LYMPHOCYTE ANTIGEN CTLA 4 1 50% 1% 1 Search CYTOTOXIC+T+LYMPHOCYTE+ANTIGEN+CTLA+4 Search CYTOTOXIC+T+LYMPHOCYTE+ANTIGEN+CTLA+4
10 DIABETIC KETOACICLOSIS 1 50% 1% 1 Search DIABETIC+KETOACICLOSIS Search DIABETIC+KETOACICLOSIS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RAPID ONSET 4 18% 12% 21
2 MAURIAC SYNDROME 4 75% 2% 3
3 HLA DQ GENOTYPE 3 100% 2% 3
4 HEPATIC GLYCOGENOSIS 3 60% 2% 3
5 GLYCOGENIC HEPATOPATHY 2 50% 2% 3
6 HEPATOSCLEROSIS 1 100% 1% 2
7 PERISINUSOIDAL FIBROSIS 1 25% 2% 3
8 3A SUBSTRATE 1 50% 1% 1
9 F ACUMINATUM 1 50% 1% 1
10 SLOWLY PROGRESSIVE IDDM 0 14% 1% 2

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners 2007 42 25 56%
Fulminant type 1 diabetes in China: a case report and review of the literature 2010 1 11 100%
Fulminant type 1 diabetes mellitus 2006 16 21 57%
Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes 2013 6 55 20%
Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide 2008 0 7 43%
Human cord blood stem cells and the journey to a cure for type 1 diabetes 2010 9 38 11%
Fulminant Type 1 Diabetes Mellitus and Fulminant Viral Myocarditis A Case Report and Literature Review 2015 0 23 30%
New hope for type 2 diabetics: Targeting insulin resistance through the immune modulation of stem cells 2011 9 77 8%
Fulminant diabetes mellitus associated with pregnancy: Case reports and literature review 2002 6 7 14%
Diabetes mellitus: Referential changes on the horizon not necessarily wellcome 2010 0 10 10%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 METAB DIABET CLIN NUTR 2 20% 5.9% 10
2 GEN INTERNAL MED METAB 1 40% 1.2% 2
3 INTERNAL MED MOL SCI B5 1 50% 0.6% 1
4 SAN FRANCISCO DIABET 1 50% 0.6% 1
5 SECT BLOOD TRANSFUS 1 50% 0.6% 1
6 AN SEVERTSOV ECOL EVOLUT PROBLEMS 0 33% 0.6% 1
7 DIABET ENDOCRINOL METAB SECT 0 33% 0.6% 1
8 DIABETOL NEPHROL 0 33% 0.6% 1
9 MIL MED HRADEC KRALOVE 0 33% 0.6% 1
10 SIBERIAN STATE MED UNIV 0 33% 0.6% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000167477 ENCEPHALOMYOCARDITIS VIRUS//EMC D//IFIH1
2 0.0000133558 ISLET CELL ANTIBODIES//IA 2//INSULIN AUTOANTIBODIES
3 0.0000108672 DIABETIC KETOACIDOSIS//KETOACIDOSIS//DKA
4 0.0000066999 IDDM2//INS VNTR//INSULIN GENE
5 0.0000056038 PROTEASE ANTIPROTEASE//RAT AND HUMAN ERYTHROCYTES//AFFECTED FACTOR
6 0.0000055150 BIOMED SURG CELL BIOL//MED CHILDRENS CLIN//RHIGF I THERAPY
7 0.0000046285 NON ALCOHOLIC FATTY LIVER DISEASE//NON ALCOHOLIC STEATOHEPATITIS//NASH
8 0.0000043415 PROINSULIN C PEPTIDE//C PEPTIDE//HUMAN C PEPTIDE
9 0.0000042159 PHOSPHORYLASE KINASE//PHOSPHORYLASE KINASE DEFICIENCY//GLYCOGEN STORAGE DISEASE TYPE IX
10 0.0000041055 NOD MOUSE//NOD MICE//JULIA MCFARLANE DIABET